Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples